REG - Cavendish Financial - Board Changes

CavendishAnnouncement

19/12/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231219:nRSS2175Xa&default-theme=true

RNS Number : 2175X  Cavendish Financial PLC  19 December 2023

 

 

Cavendish Financial Plc

Board Changes

 

19 DECEMBER 2023

Cavendish Financial plc announces that Mark Astaire has been appointed to its
Board of Directors as an independent Non-Executive Director with effect from 1
January 2024.

Mark brings over 35 years of investment banking experience to the Board having
held a number of senior leadership positions including Chairman of Corporate
Broking at Barclays and Head of Corporate Broking at Bank of America Merrill
Lynch. Mark was also a member of the Takeover Panel.

Mark is a member of the board of Sky News (which protects the editorial
independence of Sky News), a Trustee of the charity Breast Cancer Now and a
member of the International Advisory Board of the University of Edinburgh
Business School.

Robert Lister, Deputy Chairman has informed us of his intention to step down
from the Board of Directors on 31 December 2023 having led finnCap Group plc
("finnCap"), as Chairman, through its merger and subsequent integration with
Cenkos Securities plc creating Cavendish Financial Plc in September 2023.

Commenting on today's announcement, Lisa Gordon, Chair said:

"I am delighted to welcome Mark to Cavendish and look forward to working with
him.  His appointment ensures that the Board has substantial and differential
investment banking and client service experience as we continue to build on
our strategic potential following our merger in September.

Robert - as Chairman - successfully led finnCap through a period of complex
strategic and leadership change and was a tremendous partner in the creation
of the new combined Group.  On behalf of the Board, I would like to thank him
for his significant contribution to the Board both pre-merger and during the
integration of our businesses, which is now complete."

Commenting on his appointment, Mark Astaire said:

"Cavendish is a unique full-service investment bank focused on the small and
mid-market, with the largest AIM client base and strong M&A franchises
both in private and public company transactions.

I am very pleased to be joining the Board and look forward to working with
Lisa and the wider Board, to deliver on Cavendish's potential."

Further information relating to Mark Astaire as required to be disclosed under
the AIM Rules for Companies is set out below.

 

 

 

Contacts

Cavendish
(Management)
Tel: +44 (0) 20 7220 0500

Lisa Gordon, Chair
 
    investor.relations@cavendish.com

Julian Morse, Co-Chief Executive
Officer

John Farrugia, Co-Chief Executive
Officer

Ben Procter, Chief Financial Officer

 

Grant Thornton (Nominated Adviser)
                                       Tel: +44 (0) 20
7383 5100

Philip Secrett/Samantha Harrison/Ciara Donnelly

Cavendish (Broker)
 
    Tel: +44 (0) 20 7220 0500

Tim Redfern

Hudson Sandler (PR adviser)
                                                 Tel:
+44 (0) 20 7796 4133

Dan de Belder/Rebekah Chapman

 

The following information is disclosed in accordance with Rule 17 and
paragraph (g) of Schedule 2 of the AIM Rules for Companies in connection with
the appointment of Mark David Astaire, aged 64, to the Board of the Company:

 Current directorships                                     Past directorships held within the last five years

 The Wendover Foundation (Trustee of the Charity)          Breast Cancer Care (Director and Trustee of the Charity)

 Breast Cancer Now (Director and Trustee of the Charity)   The Takeover Panel

 The Goodwinds II Trust (Protector)

Mark does not hold any legal or beneficial direct or indirect interest in the
securities of the Company.

There are no other matters under paragraph (g) of Schedule 2 of the AIM Rules
to be disclosed.

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOANKFBDKBDBNBD